Suchergebnisse - "Qin, Weijun"

PubPharm (159)

1

Macrophage-Derived Nanosponges Adsorb Cytokines and Modulate Macrophage Polarization for Renal Cell Carcinoma Immunotherapy

enthalten in: Advanced healthcare materials | 2024

von Jiang, Y. | Nie, D. | Hu, Z. | +14

2

Efficacy and Safety of Disitamab Vedotin Combined with Programmed Death-1 Inhibitor for Advanced Urothelial Cancer : A Case-Series Study

enthalten in: Advances in therapy | 2024

von Zhao, H. | Xu, Z. | Li, C. | +8

3

Prognostic Significance of Grade Discrepancy Between Primary Tumor and Venous Thrombus in Nonmetastatic Clear-cell Renal Cell Carcinoma : Analysis of the REMEMBER Registry and Implications for Adjuvant Therapy

enthalten in: European urology oncology | 2024

von Wu, Z. | Chen, H. | Chen, Q. | +87

4

Detecting MRI-Invisible Prostate Cancers Using a Weakly Supervised Deep Learning Model

enthalten in: International journal of biomedical imaging | 2024

von Zheng, Y. | Zhang, J. | Huang, D. | +3

5

Endosialin in Cancer : Expression Patterns, Mechanistic Insights, and Therapeutic Approaches

enthalten in: Theranostics | 2024

von Lu, S. | Gan, L. | Lu, T. | +9

6

The PRIMARY Score : Diagnostic Performance and Added Value Compared With MRI in Detecting Clinically Significant Prostate Cancer

enthalten in: Clinical nuclear medicine | 2024

von Guo, S. | Kang, F. | Ma, S. | +5

7

Avoiding unnecessary biopsy : the combination of PRIMARY score with prostate-specific antigen density for prostate biopsy decision

enthalten in: Prostate cancer and prostatic diseases | 2023

von Guo, S. | Zhang, J. | Wang, Y. | +12

8

Small Mitochondria-Targeting Fluorophore with Multifunctional Therapeutic Activities against Prostate Cancer via the HIF1α/OATPs Pathway

enthalten in: Molecular pharmaceutics | 2023

von Qin, J. | Zhang, C. | Zhao, Y. | +6

9

Efficacy and Safety of Disitamab Vedotin Combined with Programmed Death-1 Inhibitor for Advanced Urothelial Cancer: A Case-Series Study

enthalten in: Advances in therapy | 2023

von Zhao, H. | Xu, Z. | Li, C. | +8

10

Tri-specific fusion antibody targeting PSMA/CD3/CD80 for treating prostatic cancer and application of tri-specific fusion antibody

enthalten in: Europäisches Patentamt | 2023

von QIN WEIJUN | NIE DISEN | WEN WEIHONG | +4

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[16]